Selected research
Market Structure
Global Hydrophilic Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Hydrophilic Coronary Stents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Hydrophilic Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hydrophilic Coronary Stents include Lepu Medical, USM Healthcare Medical Devices Factory, Rontis Medical, Meril Life Sciences, Genoss, Degania Silicone and Cardionovum, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Hydrophilic Coronary Stents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hydrophilic Coronary Stents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hydrophilic Coronary Stents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydrophilic Coronary Stents market size, projected growth trends, production technologies, key applications, and end-use industries.
Hydrophilic Coronary Stents Segment by Company
Lepu Medical
USM Healthcare Medical Devices Factory
Rontis Medical
Meril Life Sciences
Genoss
Degania Silicone
Cardionovum
Hydrophilic Coronary Stents Segment by Type
Metal Stents
Polymer Stents
Hydrophilic Coronary Stents Segment by Application
Drug-Eluting
Post-Procedure Management
Percutaneous Coronary Intervention (PCI)
Hydrophilic Coronary Stents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrophilic Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hydrophilic Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrophilic Coronary Stents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hydrophilic Coronary Stents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hydrophilic Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hydrophilic Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hydrophilic Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Metal Stents
- Polymer Stents
Applications
- Drug-Eluting
- Post-Procedure Management
- Percutaneous Coronary Intervention (PCI)
Companies covered
- Lepu Medical
- USM Healthcare Medical Devices Factory
- Rontis Medical
- Meril Life Sciences
- Genoss
- Degania Silicone
- Cardionovum
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hydrophilic Coronary Stents Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hydrophilic Coronary Stents Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hydrophilic Coronary Stents Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hydrophilic Coronary Stents Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hydrophilic Coronary Stents Market Dynamics
- 2.1 Hydrophilic Coronary Stents Industry Trends
- 2.2 Hydrophilic Coronary Stents Industry Drivers
- 2.3 Hydrophilic Coronary Stents Industry Opportunities and Challenges
- 2.4 Hydrophilic Coronary Stents Industry Restraints
3 Hydrophilic Coronary Stents Market by Manufacturers
- 3.1 Global Hydrophilic Coronary Stents Revenue by Manufacturers (2021-2026)
- 3.2 Global Hydrophilic Coronary Stents Sales by Manufacturers (2021-2026)
- 3.3 Global Hydrophilic Coronary Stents Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hydrophilic Coronary Stents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hydrophilic Coronary Stents Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hydrophilic Coronary Stents Manufacturers, Product Type & Application
- 3.7 Global Hydrophilic Coronary Stents Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hydrophilic Coronary Stents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hydrophilic Coronary Stents Players Market Share by Revenue in 2025
- 3.8.3 2025 Hydrophilic Coronary Stents Tier 1, Tier 2, and Tier 3
4 Hydrophilic Coronary Stents Market by Type
- 4.1 Hydrophilic Coronary Stents Type Introduction
- 4.1.1 Metal Stents
- 4.1.2 Polymer Stents
- 4.2 Global Hydrophilic Coronary Stents Sales by Type
- 4.2.1 Global Hydrophilic Coronary Stents Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hydrophilic Coronary Stents Sales by Type (2021-2032)
- 4.2.3 Global Hydrophilic Coronary Stents Sales Market Share by Type (2021-2032)
- 4.3 Global Hydrophilic Coronary Stents Revenue by Type
- 4.3.1 Global Hydrophilic Coronary Stents Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hydrophilic Coronary Stents Revenue by Type (2021-2032)
- 4.3.3 Global Hydrophilic Coronary Stents Revenue Market Share by Type (2021-2032)
5 Hydrophilic Coronary Stents Market by Application
- 5.1 Hydrophilic Coronary Stents Application Introduction
- 5.1.1 Drug-Eluting
- 5.1.2 Post-Procedure Management
- 5.1.3 Percutaneous Coronary Intervention (PCI)
- 5.2 Global Hydrophilic Coronary Stents Sales by Application
- 5.2.1 Global Hydrophilic Coronary Stents Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hydrophilic Coronary Stents Sales by Application (2021-2032)
- 5.2.3 Global Hydrophilic Coronary Stents Sales Market Share by Application (2021-2032)
- 5.3 Global Hydrophilic Coronary Stents Revenue by Application
- 5.3.1 Global Hydrophilic Coronary Stents Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hydrophilic Coronary Stents Revenue by Application (2021-2032)
- 5.3.3 Global Hydrophilic Coronary Stents Revenue Market Share by Application (2021-2032)
6 Global Hydrophilic Coronary Stents Sales by Region
- 6.1 Global Hydrophilic Coronary Stents Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hydrophilic Coronary Stents Sales by Region (2021-2032)
- 6.2.1 Global Hydrophilic Coronary Stents Sales by Region (2021-2026)
- 6.2.2 Global Hydrophilic Coronary Stents Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hydrophilic Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hydrophilic Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hydrophilic Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hydrophilic Coronary Stents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hydrophilic Coronary Stents Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hydrophilic Coronary Stents Revenue by Region
- 7.1 Global Hydrophilic Coronary Stents Revenue by Region
- 7.1.1 Global Hydrophilic Coronary Stents Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hydrophilic Coronary Stents Revenue by Region (2021-2026)
- 7.1.3 Global Hydrophilic Coronary Stents Revenue by Region (2027-2032)
- 7.1.4 Global Hydrophilic Coronary Stents Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hydrophilic Coronary Stents Revenue (2021-2032)
- 7.2.2 North America Hydrophilic Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hydrophilic Coronary Stents Revenue (2021-2032)
- 7.3.2 Europe Hydrophilic Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hydrophilic Coronary Stents Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hydrophilic Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hydrophilic Coronary Stents Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hydrophilic Coronary Stents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Lepu Medical
- 8.1.1 Lepu Medical Company Information
- 8.1.2 Lepu Medical Business Overview
- 8.1.3 Lepu Medical Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Lepu Medical Hydrophilic Coronary Stents Product Portfolio
- 8.1.5 Lepu Medical Recent Developments
- 8.2 USM Healthcare Medical Devices Factory
- 8.2.1 USM Healthcare Medical Devices Factory Company Information
- 8.2.2 USM Healthcare Medical Devices Factory Business Overview
- 8.2.3 USM Healthcare Medical Devices Factory Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 USM Healthcare Medical Devices Factory Hydrophilic Coronary Stents Product Portfolio
- 8.2.5 USM Healthcare Medical Devices Factory Recent Developments
- 8.3 Rontis Medical
- 8.3.1 Rontis Medical Company Information
- 8.3.2 Rontis Medical Business Overview
- 8.3.3 Rontis Medical Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Rontis Medical Hydrophilic Coronary Stents Product Portfolio
- 8.3.5 Rontis Medical Recent Developments
- 8.4 Meril Life Sciences
- 8.4.1 Meril Life Sciences Company Information
- 8.4.2 Meril Life Sciences Business Overview
- 8.4.3 Meril Life Sciences Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Meril Life Sciences Hydrophilic Coronary Stents Product Portfolio
- 8.4.5 Meril Life Sciences Recent Developments
- 8.5 Genoss
- 8.5.1 Genoss Company Information
- 8.5.2 Genoss Business Overview
- 8.5.3 Genoss Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Genoss Hydrophilic Coronary Stents Product Portfolio
- 8.5.5 Genoss Recent Developments
- 8.6 Degania Silicone
- 8.6.1 Degania Silicone Company Information
- 8.6.2 Degania Silicone Business Overview
- 8.6.3 Degania Silicone Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Degania Silicone Hydrophilic Coronary Stents Product Portfolio
- 8.6.5 Degania Silicone Recent Developments
- 8.7 Cardionovum
- 8.7.1 Cardionovum Company Information
- 8.7.2 Cardionovum Business Overview
- 8.7.3 Cardionovum Hydrophilic Coronary Stents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Cardionovum Hydrophilic Coronary Stents Product Portfolio
- 8.7.5 Cardionovum Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hydrophilic Coronary Stents Value Chain Analysis
- 9.1.1 Hydrophilic Coronary Stents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hydrophilic Coronary Stents Production Mode & Process
- 9.2 Hydrophilic Coronary Stents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hydrophilic Coronary Stents Distributors
- 9.2.3 Hydrophilic Coronary Stents Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst